GRAIL sets new 52-week high as FDA panel backs cancer test
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
3 Medicare Assumptions You Need to Clear Up Before Open Enrollment
Key PointsMedicare open enrollment kicks off on Oct. 15.
US patients sue Ozempic, Mounjaro makers over vision loss
The development comes as GLP-1 medicines become increasingly available in Nigeria, where a recent PREMIUM TIMES investigation found that the injections were being sold online without prescriptions or…
Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs?
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
Congo running short of health workers as Ebola outbreak spreads, WHO says
The Ebola outbreak has spread to seven provinces, with 7,773 confirmed cases and 3,759 deaths, according to the latest government figures.
Smart contact lens detects serotonin changes in tear samples collected during stress test
A research team led by Dr. Yangzhi Zhu, principal investigator and assistant professor at the Terasaki Institute for Biomedical Innovation, has developed a soft, reusable smart contact lens as part of…
Fighting depression with humor: Laughter can bring relief, but not every moment is right
Comedian Robin Williams once said that every time you get depressed, comedy will be there to drag you out of it. But does humor really help?